recognized the involvement of anti-β2GPI/HLA-DR antibody, which targets the complex formed by β2-glycoprotein I (β2GPI) and HLA-DR, in the pathogenesis of recurrent pregnancy loss (RPL) (10) and pregnancy complications associated with antiphospholipid syndrome (APS) (11). Here, APOH is linked to antiphospholipid syndrome.